JP2020511529A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020511529A5 JP2020511529A5 JP2019568594A JP2019568594A JP2020511529A5 JP 2020511529 A5 JP2020511529 A5 JP 2020511529A5 JP 2019568594 A JP2019568594 A JP 2019568594A JP 2019568594 A JP2019568594 A JP 2019568594A JP 2020511529 A5 JP2020511529 A5 JP 2020511529A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- stimulus
- vector
- cell
- payload
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims description 76
- 108010019670 Chimeric Antigen Receptors Proteins 0.000 claims description 31
- 210000004027 cell Anatomy 0.000 claims description 27
- 102000040430 polynucleotide Human genes 0.000 claims description 27
- 108091033319 polynucleotide Proteins 0.000 claims description 27
- 239000002157 polynucleotide Substances 0.000 claims description 27
- 239000013598 vector Substances 0.000 claims description 27
- 150000001413 amino acids Chemical class 0.000 claims description 21
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 20
- 239000002955 immunomodulating agent Substances 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 17
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims description 15
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims description 14
- 230000006870 function Effects 0.000 claims description 14
- 210000002865 immune cell Anatomy 0.000 claims description 14
- 239000012636 effector Substances 0.000 claims description 13
- 206010028980 Neoplasm Diseases 0.000 claims description 11
- 102000005962 receptors Human genes 0.000 claims description 11
- 108020003175 receptors Proteins 0.000 claims description 11
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 10
- 230000004927 fusion Effects 0.000 claims description 9
- 230000035772 mutation Effects 0.000 claims description 9
- 230000001105 regulatory effect Effects 0.000 claims description 9
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 claims description 8
- 229960000485 methotrexate Drugs 0.000 claims description 8
- 229920001184 polypeptide Polymers 0.000 claims description 8
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- 239000013603 viral vector Substances 0.000 claims description 8
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 7
- 102000004127 Cytokines Human genes 0.000 claims description 7
- 108090000695 Cytokines Proteins 0.000 claims description 7
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 6
- 108091027981 Response element Proteins 0.000 claims description 6
- 201000011510 cancer Diseases 0.000 claims description 4
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 claims description 4
- 230000001687 destabilization Effects 0.000 claims description 4
- 230000004068 intracellular signaling Effects 0.000 claims description 4
- 230000001177 retroviral effect Effects 0.000 claims description 4
- 230000006641 stabilisation Effects 0.000 claims description 4
- 238000011105 stabilization Methods 0.000 claims description 4
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 claims description 4
- 102220526135 Dihydrofolate reductase_N65F_mutation Human genes 0.000 claims description 3
- 108010076504 Protein Sorting Signals Proteins 0.000 claims description 3
- 210000001744 T-lymphocyte Anatomy 0.000 claims description 3
- 230000028993 immune response Effects 0.000 claims description 3
- 230000001939 inductive effect Effects 0.000 claims description 3
- 210000004698 lymphocyte Anatomy 0.000 claims description 3
- 108020004999 messenger RNA Proteins 0.000 claims description 3
- 230000008685 targeting Effects 0.000 claims description 3
- 239000013607 AAV vector Substances 0.000 claims description 2
- 108020004414 DNA Proteins 0.000 claims description 2
- 102000053602 DNA Human genes 0.000 claims description 2
- 102220526133 Dihydrofolate reductase_Q36K_mutation Human genes 0.000 claims description 2
- 102000013462 Interleukin-12 Human genes 0.000 claims description 2
- 108010065805 Interleukin-12 Proteins 0.000 claims description 2
- 102000003812 Interleukin-15 Human genes 0.000 claims description 2
- 108090000172 Interleukin-15 Proteins 0.000 claims description 2
- 238000003776 cleavage reaction Methods 0.000 claims description 2
- 210000004443 dendritic cell Anatomy 0.000 claims description 2
- 230000000368 destabilizing effect Effects 0.000 claims description 2
- 210000001671 embryonic stem cell Anatomy 0.000 claims description 2
- 210000002443 helper t lymphocyte Anatomy 0.000 claims description 2
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims description 2
- 210000003071 memory t lymphocyte Anatomy 0.000 claims description 2
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims description 2
- 210000000581 natural killer T-cell Anatomy 0.000 claims description 2
- 239000013612 plasmid Substances 0.000 claims description 2
- 230000007017 scission Effects 0.000 claims description 2
- 230000000638 stimulation Effects 0.000 claims description 2
- 201000010099 disease Diseases 0.000 claims 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 7
- 230000004044 response Effects 0.000 claims 5
- 108090000790 Enzymes Proteins 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 230000000139 costimulatory effect Effects 0.000 claims 1
- OZRNSSUDZOLUSN-LBPRGKRZSA-N dihydrofolic acid Chemical compound N=1C=2C(=O)NC(N)=NC=2NCC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OZRNSSUDZOLUSN-LBPRGKRZSA-N 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000007026 protein scission Effects 0.000 claims 1
- 150000003384 small molecules Chemical class 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 241001430294 unidentified retrovirus Species 0.000 claims 1
- 101000908713 Homo sapiens Dihydrofolate reductase Proteins 0.000 description 61
- 239000012634 fragment Substances 0.000 description 8
- 239000000427 antigen Substances 0.000 description 7
- 108091007433 antigens Proteins 0.000 description 7
- 102000036639 antigens Human genes 0.000 description 7
- 108091008874 T cell receptors Proteins 0.000 description 5
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 5
- 102220242566 rs754509338 Human genes 0.000 description 5
- 102220503901 Meiotic recombination protein REC8 homolog_D142G_mutation Human genes 0.000 description 4
- 102200080790 rs1057520333 Human genes 0.000 description 4
- -1 CD8α Proteins 0.000 description 3
- 102220640185 Mitochondrial 2-oxoglutarate/malate carrier protein_K99R_mutation Human genes 0.000 description 3
- 230000000890 antigenic effect Effects 0.000 description 3
- 102220140761 rs761526437 Human genes 0.000 description 3
- 102220159135 rs764865890 Human genes 0.000 description 3
- 102220227609 rs913563840 Human genes 0.000 description 3
- 102220546996 Actin, gamma-enteric smooth muscle_I72K_mutation Human genes 0.000 description 2
- 102100038080 B-cell receptor CD22 Human genes 0.000 description 2
- 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 description 2
- 102100024746 Dihydrofolate reductase Human genes 0.000 description 2
- 102100029360 Hematopoietic cell signal transducer Human genes 0.000 description 2
- 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 description 2
- 101000990188 Homo sapiens Hematopoietic cell signal transducer Proteins 0.000 description 2
- 101001137987 Homo sapiens Lymphocyte activation gene 3 protein Proteins 0.000 description 2
- 101000946860 Homo sapiens T-cell surface glycoprotein CD3 epsilon chain Proteins 0.000 description 2
- 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 2
- 101000851370 Homo sapiens Tumor necrosis factor receptor superfamily member 9 Proteins 0.000 description 2
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 2
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 2
- 102000017578 LAG3 Human genes 0.000 description 2
- 108010021466 Mutant Proteins Proteins 0.000 description 2
- 102000008300 Mutant Proteins Human genes 0.000 description 2
- 102100035794 T-cell surface glycoprotein CD3 epsilon chain Human genes 0.000 description 2
- 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 2
- 102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 description 2
- 101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 description 2
- 102100036856 Tumor necrosis factor receptor superfamily member 9 Human genes 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 108020001096 dihydrofolate reductase Proteins 0.000 description 2
- 102200013899 rs10258719 Human genes 0.000 description 2
- 102200009188 rs148176750 Human genes 0.000 description 2
- 102220257199 rs1553408408 Human genes 0.000 description 2
- 102220283791 rs1555932650 Human genes 0.000 description 2
- 102220269760 rs182535774 Human genes 0.000 description 2
- 102200065445 rs193929333 Human genes 0.000 description 2
- 102220005448 rs28928876 Human genes 0.000 description 2
- 102200127053 rs34177811 Human genes 0.000 description 2
- 102220061202 rs786203440 Human genes 0.000 description 2
- 102220072342 rs794728994 Human genes 0.000 description 2
- 102220087418 rs864622444 Human genes 0.000 description 2
- 102220087233 rs864622667 Human genes 0.000 description 2
- 102220096012 rs876658305 Human genes 0.000 description 2
- 230000011664 signaling Effects 0.000 description 2
- 102100023990 60S ribosomal protein L17 Human genes 0.000 description 1
- 102220495814 Actin-like protein 10_K156R_mutation Human genes 0.000 description 1
- 101710145634 Antigen 1 Proteins 0.000 description 1
- 102100027207 CD27 antigen Human genes 0.000 description 1
- 101150013553 CD40 gene Proteins 0.000 description 1
- 102100032937 CD40 ligand Human genes 0.000 description 1
- 102100037904 CD9 antigen Human genes 0.000 description 1
- 108010021064 CTLA-4 Antigen Proteins 0.000 description 1
- 229940045513 CTLA4 antagonist Drugs 0.000 description 1
- 102100025466 Carcinoembryonic antigen-related cell adhesion molecule 3 Human genes 0.000 description 1
- 102220578645 Chorion-specific transcription factor GCMb_N65A_mutation Human genes 0.000 description 1
- 102220578647 Chorion-specific transcription factor GCMb_N65D_mutation Human genes 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 102220553748 Cyclic GMP-AMP synthase_K47R_mutation Human genes 0.000 description 1
- 102220626226 DNA-directed primase/polymerase protein_M112T_mutation Human genes 0.000 description 1
- 101100189582 Dictyostelium discoideum pdeD gene Proteins 0.000 description 1
- 102220526130 Dihydrofolate reductase_N65S_mutation Human genes 0.000 description 1
- 102220526132 Dihydrofolate reductase_Q36S_mutation Human genes 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- 101150029707 ERBB2 gene Proteins 0.000 description 1
- 102220545605 Endonuclease III-like protein 1_I176T_mutation Human genes 0.000 description 1
- 102100026122 High affinity immunoglobulin gamma Fc receptor I Human genes 0.000 description 1
- 101100383038 Homo sapiens CD19 gene Proteins 0.000 description 1
- 101000914511 Homo sapiens CD27 antigen Proteins 0.000 description 1
- 101000738354 Homo sapiens CD9 antigen Proteins 0.000 description 1
- 101000914337 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 3 Proteins 0.000 description 1
- 101000913074 Homo sapiens High affinity immunoglobulin gamma Fc receptor I Proteins 0.000 description 1
- 101000777628 Homo sapiens Leukocyte antigen CD37 Proteins 0.000 description 1
- 101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 description 1
- 101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 description 1
- 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 description 1
- 101001109503 Homo sapiens NKG2-C type II integral membrane protein Proteins 0.000 description 1
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 1
- 101000934341 Homo sapiens T-cell surface glycoprotein CD5 Proteins 0.000 description 1
- 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 description 1
- 101000809875 Homo sapiens TYRO protein tyrosine kinase-binding protein Proteins 0.000 description 1
- 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 description 1
- 108090000144 Human Proteins Proteins 0.000 description 1
- 102000003839 Human Proteins Human genes 0.000 description 1
- 102220511074 Hydroxycarboxylic acid receptor 3_E31D_mutation Human genes 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
- 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
- 102220517095 Jerky protein homolog-like_I72V_mutation Human genes 0.000 description 1
- 102100031586 Leukocyte antigen CD37 Human genes 0.000 description 1
- 102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 description 1
- 241000282560 Macaca mulatta Species 0.000 description 1
- 101710141452 Major surface glycoprotein G Proteins 0.000 description 1
- 108010061593 Member 14 Tumor Necrosis Factor Receptors Proteins 0.000 description 1
- 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 description 1
- 102220525890 NADH-ubiquinone oxidoreductase chain 4L_I61T_mutation Human genes 0.000 description 1
- 102100022683 NKG2-C type II integral membrane protein Human genes 0.000 description 1
- 108010017405 NRH - quinone oxidoreductase2 Proteins 0.000 description 1
- 101150098694 PDE5A gene Proteins 0.000 description 1
- 102000000536 PPAR gamma Human genes 0.000 description 1
- 108010016731 PPAR gamma Proteins 0.000 description 1
- 108010079855 Peptide Aptamers Proteins 0.000 description 1
- 102220491272 Peripheral myelin protein 22_L80P_mutation Human genes 0.000 description 1
- 102220516830 Peroxisomal membrane protein PEX14_K56E_mutation Human genes 0.000 description 1
- 102220640878 Pregnancy-specific beta-1-glycoprotein 3_L23S_mutation Human genes 0.000 description 1
- 102220533819 Protein BEX2_K19E_mutation Human genes 0.000 description 1
- 102220467332 Protein BEX4_L94A_mutation Human genes 0.000 description 1
- 102220621011 Protein SGT1 homolog_Y157R_mutation Human genes 0.000 description 1
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 1
- 102100022353 Ribosyldihydronicotinamide dehydrogenase [quinone] Human genes 0.000 description 1
- 102220561604 SH2B adapter protein 2_W114R_mutation Human genes 0.000 description 1
- 102100025244 T-cell surface glycoprotein CD5 Human genes 0.000 description 1
- 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 description 1
- 102100038717 TYRO protein tyrosine kinase-binding protein Human genes 0.000 description 1
- 102000018679 Tacrolimus Binding Proteins Human genes 0.000 description 1
- 108010027179 Tacrolimus Binding Proteins Proteins 0.000 description 1
- 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 1
- 102100028785 Tumor necrosis factor receptor superfamily member 14 Human genes 0.000 description 1
- 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 1
- 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 description 1
- 230000000735 allogeneic effect Effects 0.000 description 1
- 102220419550 c.160G>A Human genes 0.000 description 1
- 102220349478 c.40T>A Human genes 0.000 description 1
- 102220383755 c.422A>G Human genes 0.000 description 1
- 102220363676 c.444T>G Human genes 0.000 description 1
- 102220398030 c.50T>A Human genes 0.000 description 1
- 102200061322 c.551A>G Human genes 0.000 description 1
- 102100029175 cGMP-specific 3',5'-cyclic phosphodiesterase Human genes 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000031146 intracellular signal transduction Effects 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002823 phage display Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 102200081454 rs1048108 Human genes 0.000 description 1
- 102220010999 rs104894360 Human genes 0.000 description 1
- 102220195383 rs1057517839 Human genes 0.000 description 1
- 102200052983 rs1137100 Human genes 0.000 description 1
- 102200111538 rs117209107 Human genes 0.000 description 1
- 102200058933 rs121909535 Human genes 0.000 description 1
- 102220280971 rs1253463092 Human genes 0.000 description 1
- 102220289727 rs1253463092 Human genes 0.000 description 1
- 102200090745 rs137852499 Human genes 0.000 description 1
- 102200026990 rs137852764 Human genes 0.000 description 1
- 102220078654 rs147697562 Human genes 0.000 description 1
- 102220288810 rs1554539977 Human genes 0.000 description 1
- 102200004203 rs199472685 Human genes 0.000 description 1
- 102220271089 rs200048921 Human genes 0.000 description 1
- 102220150245 rs200516165 Human genes 0.000 description 1
- 102220294276 rs202032682 Human genes 0.000 description 1
- 102200068687 rs281865206 Human genes 0.000 description 1
- 102200068694 rs281865207 Human genes 0.000 description 1
- 102200065572 rs28364364 Human genes 0.000 description 1
- 102200037023 rs387907270 Human genes 0.000 description 1
- 102220021057 rs397508897 Human genes 0.000 description 1
- 102200164348 rs41295282 Human genes 0.000 description 1
- 102220326936 rs45517095 Human genes 0.000 description 1
- 102220044643 rs587781450 Human genes 0.000 description 1
- 102200001847 rs587782995 Human genes 0.000 description 1
- 102200027869 rs62517167 Human genes 0.000 description 1
- 102200103842 rs6436669 Human genes 0.000 description 1
- 102220032039 rs67418243 Human genes 0.000 description 1
- 102200101879 rs72556290 Human genes 0.000 description 1
- 102200101881 rs72556293 Human genes 0.000 description 1
- 102220057450 rs730881811 Human genes 0.000 description 1
- 102220286181 rs730881811 Human genes 0.000 description 1
- 102200094314 rs74315399 Human genes 0.000 description 1
- 102220232854 rs766277488 Human genes 0.000 description 1
- 102220082831 rs780379280 Human genes 0.000 description 1
- 102220063397 rs786204865 Human genes 0.000 description 1
- 102220323326 rs796360127 Human genes 0.000 description 1
- 102220022272 rs80357266 Human genes 0.000 description 1
- 102200067619 rs80357382 Human genes 0.000 description 1
- 102220119381 rs886042300 Human genes 0.000 description 1
- 102220235606 rs925977838 Human genes 0.000 description 1
- 102220279469 rs992385562 Human genes 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 102000003298 tumor necrosis factor receptor Human genes 0.000 description 1
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2023139792A JP2023164900A (ja) | 2017-03-03 | 2023-08-30 | 免疫療法のためのcd19組成物及び方法 |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762466601P | 2017-03-03 | 2017-03-03 | |
US62/466,601 | 2017-03-03 | ||
US201762484052P | 2017-04-11 | 2017-04-11 | |
US62/484,052 | 2017-04-11 | ||
PCT/US2018/020741 WO2018161017A1 (en) | 2017-03-03 | 2018-03-02 | Cd19 compositions and methods for immunotherapy |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2023139792A Division JP2023164900A (ja) | 2017-03-03 | 2023-08-30 | 免疫療法のためのcd19組成物及び方法 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2020511529A JP2020511529A (ja) | 2020-04-16 |
JP2020511529A5 true JP2020511529A5 (enrdf_load_stackoverflow) | 2021-04-15 |
JP7341900B2 JP7341900B2 (ja) | 2023-09-11 |
Family
ID=63371272
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019568594A Active JP7341900B2 (ja) | 2017-03-03 | 2018-03-02 | 免疫療法のためのcd19組成物及び方法 |
JP2023139792A Pending JP2023164900A (ja) | 2017-03-03 | 2023-08-30 | 免疫療法のためのcd19組成物及び方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2023139792A Pending JP2023164900A (ja) | 2017-03-03 | 2023-08-30 | 免疫療法のためのcd19組成物及び方法 |
Country Status (8)
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10704021B2 (en) | 2012-03-15 | 2020-07-07 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
WO2015105955A1 (en) | 2014-01-08 | 2015-07-16 | Flodesign Sonics, Inc. | Acoustophoresis device with dual acoustophoretic chamber |
US11377651B2 (en) | 2016-10-19 | 2022-07-05 | Flodesign Sonics, Inc. | Cell therapy processes utilizing acoustophoresis |
US11708572B2 (en) | 2015-04-29 | 2023-07-25 | Flodesign Sonics, Inc. | Acoustic cell separation techniques and processes |
US11214789B2 (en) | 2016-05-03 | 2022-01-04 | Flodesign Sonics, Inc. | Concentration and washing of particles with acoustics |
CN111107866A (zh) | 2017-06-12 | 2020-05-05 | 黑曜石疗法公司 | 用于免疫疗法的pde5组合物和方法 |
JP2021507561A (ja) | 2017-12-14 | 2021-02-22 | フロデザイン ソニックス, インク.Flodesign Sonics, Inc. | 音響トランスデューサドライバ及びコントローラ |
AU2018385756A1 (en) * | 2017-12-15 | 2020-07-09 | Aleta Biotherapeutics Inc. | CD19 variants |
CN119752803A (zh) * | 2018-08-01 | 2025-04-04 | 南克维斯特公司 | 用于免疫疗法的基因修饰的包含归巢受体或细胞因子和嵌合抗原受体的四顺反子系统 |
EP3856910B1 (en) * | 2018-09-24 | 2024-11-20 | Merck Sharp & Dohme LLC | Expression vectors for eukaryotic expression systems |
IL277414B2 (en) * | 2018-11-06 | 2025-04-01 | Immunitybio Inc | NK–92 cells with chimeric antigen receptor modification |
US12109238B2 (en) | 2018-11-06 | 2024-10-08 | Immunitybio, Inc. | Chimeric antigen receptor-modified NK-92 cells |
CN118497276A (zh) * | 2018-11-07 | 2024-08-16 | 阿库斯股份有限公司 | 腺相关病毒载体用于在内耳中的毛细胞和支持细胞中校正基因缺陷/表达蛋白质的用途 |
EP3894011A1 (en) * | 2018-12-11 | 2021-10-20 | Obsidian Therapeutics, Inc. | Membrane bound il12 compositions and methods for tunable regulation |
CN116479022A (zh) * | 2018-12-12 | 2023-07-25 | 中南大学 | 一种重组car19-il24基因、慢病毒载体、car19-il24-t细胞及应用 |
WO2020123691A2 (en) | 2018-12-12 | 2020-06-18 | Kite Pharma, Inc | Chimeric antigen and t cell receptors and methods of use |
WO2020156335A1 (zh) * | 2019-01-29 | 2020-08-06 | 上海交通大学 | 一种嵌合抗原受体及其应用 |
CN113423720A (zh) | 2019-02-04 | 2021-09-21 | 国立大学法人爱媛大学 | CAR文库和scFv的制造方法 |
AU2020224160A1 (en) * | 2019-02-21 | 2021-08-26 | John M. LUK | Artificial immunosurveillance chimeric antigen receptor (AI-CAR) and cells expressing the same |
CN113811549A (zh) | 2019-02-21 | 2021-12-17 | Xencor股份有限公司 | 非靶向和靶向性il-10 fc融合蛋白 |
US20220144917A1 (en) | 2019-03-01 | 2022-05-12 | Universität Für Bodenkultur Wien | Stabilized extracellular domain of cd19 |
MX2021010670A (es) | 2019-03-05 | 2021-11-12 | Nkarta Inc | Receptores de antigeno quimerico dirigidos a cd19 y usos de los mismos en inmunoterapia. |
BR112021017770A2 (pt) * | 2019-03-08 | 2021-11-16 | Obsidian Therapeutics Inc | Composições e métodos de cd40l para regulação ajustável |
BR112021017744A2 (pt) * | 2019-03-08 | 2021-11-16 | Obsidian Therapeutics Inc | Composições e métodos de cd40l para regulação ajustável |
WO2020190771A1 (en) * | 2019-03-15 | 2020-09-24 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Chimeric adaptor and kinase signaling proteins and their use in immunotherapy |
PE20212369A1 (es) | 2019-04-26 | 2021-12-21 | Allogene Therapeutics Inc | Receptores de antigenos quimericos resistentes a rituximab y usos de estos |
CN110079504A (zh) * | 2019-05-06 | 2019-08-02 | 山东大学第二医院 | 一种含有不稳定结构域的car-t细胞及其制备方法和调节car-t细胞功能方法 |
CN110075275B (zh) * | 2019-05-15 | 2023-03-24 | 苏州大学 | IL-36β的应用 |
EP3976196A4 (en) * | 2019-05-29 | 2023-06-14 | Orbis Health Solutions, LLC | Delivery vectors and particles for expressing chimeric receptors and methods of using the same |
BR112021025022A2 (pt) * | 2019-06-12 | 2022-02-22 | Obsidian Therapeutics Inc | Composições de ca2 e métodos para regulação ajustáveis |
CN110818803B (zh) * | 2019-07-24 | 2023-01-03 | 浙江启新生物技术有限公司 | 分泌表达il15ra-il15融合蛋白、ccl21趋化因子的嵌合抗原受体-t细胞及应用 |
WO2021034952A1 (en) * | 2019-08-19 | 2021-02-25 | Elpis Biopharmaceuticals | Anti-cd19 antibodies and uses thereof |
CA3149543A1 (en) * | 2019-08-27 | 2021-03-04 | Donald M. O'rourke | Synthetic cars to treat il13r.alpha.2 positive human and canine tumors |
WO2021040736A1 (en) | 2019-08-30 | 2021-03-04 | Obsidian Therapeutics, Inc. | Tandem cd19 car-based compositions and methods for immunotherapy |
WO2021046451A1 (en) * | 2019-09-06 | 2021-03-11 | Obsidian Therapeutics, Inc. | Compositions and methods for dhfr tunable protein regulation |
CA3150224A1 (en) | 2019-09-10 | 2021-03-18 | Obsidian Therapeutics, Inc. | Ca2 compositions and methods for tunable regulation |
CA3154280A1 (en) * | 2019-10-11 | 2021-04-15 | The Trustees Of The University Of Pennsylvania | Compositions and methods for targeting cd13 and tim-3 with car t cells to treat acute myeloid leukemia |
AU2020394427A1 (en) * | 2019-11-27 | 2022-07-14 | The Trustees Of The University Of Pennsylvania | Anti-CD3 scFv and cytokine producing artificial antigen presenting cells |
AU2020393906A1 (en) * | 2019-11-27 | 2022-06-23 | Board Of Regents, The University Of Texas System | Large-scale combined car transduction and CRISPR gene editing of T cells |
MX2022008415A (es) * | 2020-01-08 | 2022-08-08 | Obsidian Therapeutics Inc | Composiciones y metodos para la regulacion ajustable de la transcripcion. |
US11230699B2 (en) | 2020-01-28 | 2022-01-25 | Immunitybio, Inc. | Chimeric antigen receptor-modified NK-92 cells targeting EGFR super-family receptors |
KR20220167276A (ko) * | 2020-03-10 | 2022-12-20 | 매사추세츠 인스티튜트 오브 테크놀로지 | NPM1c-양성 암의 면역치료를 위한 조성물 및 방법 |
EP4204560A4 (en) * | 2020-09-02 | 2024-10-16 | Nkarta, Inc. | ENHANCED EXPANSION AND CYTOTOXICITY OF MODIFIED NATURAL KILLER CELLS AND RELATED USES |
EP4209593A4 (en) * | 2020-09-04 | 2024-10-09 | Heartseed Inc. | IPS CELL QUALITY IMPROVING AGENT, METHOD FOR PRODUCING IPS CELLS, IPS CELLS, AND COMPOSITION FOR PRODUCING IPS CELLS |
US20240002479A1 (en) * | 2020-11-23 | 2024-01-04 | The Regents Of The University Of Michigan | Single-chain antibody against flavivirus ns1 protein |
CN112795543B (zh) * | 2021-02-04 | 2022-09-27 | 华中农业大学 | 杂交瘤细胞株及其分泌的抗草鱼IL-15Rα单克隆抗体和应用 |
CN113403274B (zh) * | 2021-06-28 | 2023-11-10 | 上海睿臻迈生物医疗科技有限公司 | 细胞治疗组合物及其制备方法和作为过敏性反应及自身免疫疾病治疗药物的应用 |
CN113736810B (zh) * | 2021-09-08 | 2024-05-24 | 苏州因特药物研发有限公司 | 构建体、载体、蛋白、细胞、制备方法、产品及应用 |
CN114129718B (zh) * | 2021-10-19 | 2024-05-03 | 华东师范大学 | 一种用于体内自组装car-t的纳米递送系统及其制备方法和应用 |
CN114558126B (zh) * | 2021-11-04 | 2024-11-08 | 苏州大学附属第一医院 | 序贯输注cd19 car-t和bcma car-t细胞在急性白血病患者免疫介导血小板输注无效中的联合应用 |
WO2023174405A1 (zh) * | 2022-03-18 | 2023-09-21 | 广东东阳光药业股份有限公司 | Claudin18.2人源化抗体及其应用 |
EP4551246A1 (en) | 2022-07-05 | 2025-05-14 | Neomics Pharmaceuticals LLC | Chimeric antigen receptor comprising bcma nanobody linked to a chimeric intracellular signaling domain |
WO2024189583A1 (en) * | 2023-03-15 | 2024-09-19 | Kyoto Prefectural Public University Corporation | Peptide expression constructs and uses thereof |
CN116516007B (zh) * | 2023-04-18 | 2024-01-19 | 华中科技大学同济医学院附属协和医院 | Cd19表达的检测方法 |
CN116536375B (zh) * | 2023-06-28 | 2023-11-10 | 北京大学深圳研究生院 | merocyclophanes类化合物的化学-酶法合成方法及其应用 |
WO2025160432A1 (en) * | 2024-01-26 | 2025-07-31 | Poseida Therapeutics, Inc. | Methods and compositions for enhancing in vivo persistence and potency of cell therapy |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1648512A4 (en) * | 2003-07-31 | 2009-01-21 | Immunomedics Inc | ANTI-CD19 ANTIBODIES |
US20130266551A1 (en) * | 2003-11-05 | 2013-10-10 | St. Jude Children's Research Hospital, Inc. | Chimeric receptors with 4-1bb stimulatory signaling domain |
KR100787393B1 (ko) * | 2006-03-23 | 2007-12-21 | 학교법인 한림대학교 | 세포 도입성 fk506 결합 단백질의 융합 단백질 |
US8173792B2 (en) * | 2007-02-09 | 2012-05-08 | The Board Of Trustees Of The Leland Stanford Junior University | Method for regulating protein function in cells using synthetic small molecules |
US8530636B2 (en) * | 2008-05-07 | 2013-09-10 | The Board Of Trustees Of The Leland Stanford Junior University | Method for regulating protein function in cells in vivo using synthetic small molecules |
PH12013501201A1 (en) * | 2010-12-09 | 2013-07-29 | Univ Pennsylvania | Use of chimeric antigen receptor-modified t cells to treat cancer |
CN103946242A (zh) * | 2011-10-20 | 2014-07-23 | 美国卫生和人力服务部 | 抗cd22嵌合抗原受体 |
WO2013172926A1 (en) * | 2012-05-14 | 2013-11-21 | Yale University | Immune biomarkers and assays predictive of clinical response to immunotherapy for cancer |
ES2758227T3 (es) * | 2013-02-15 | 2020-05-04 | Univ California | Receptor de antígeno quimérico y métodos de uso del mismo |
WO2014152932A1 (en) * | 2013-03-14 | 2014-09-25 | Board Of Regents, The University Of Texas System | Mirna for treating cancer and for use with adoptive immunotherapies |
KR102095700B1 (ko) * | 2013-05-14 | 2020-04-01 | 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 | 가공된 키메라 항원 수용체 (car) t-세포의 인간 적용 |
WO2015028574A1 (en) * | 2013-08-28 | 2015-03-05 | Pci Biotech As | Compound and method for vaccination and immunisation |
KR102339240B1 (ko) * | 2013-10-15 | 2021-12-15 | 더 스크립스 리서치 인스티튜트 | 펩타이드 키메라 항원 수용체 t 세포 스위치 및 이의 용도 |
EP3245288A1 (en) * | 2015-01-12 | 2017-11-22 | Pieris Pharmaceuticals GmbH | Engineered t cells and uses therefor |
WO2016134284A1 (en) * | 2015-02-19 | 2016-08-25 | University Of Florida Research Foundation, Inc. | Chimeric antigen receptors and uses thereof |
WO2017180587A2 (en) * | 2016-04-11 | 2017-10-19 | Obsidian Therapeutics, Inc. | Regulated biocircuit systems |
TW202508628A (zh) * | 2016-07-28 | 2025-03-01 | 瑞士商諾華公司 | 嵌合抗原受體及pd-1抑制劑之組合療法 |
CN111107866A (zh) * | 2017-06-12 | 2020-05-05 | 黑曜石疗法公司 | 用于免疫疗法的pde5组合物和方法 |
-
2018
- 2018-03-02 EP EP18760420.2A patent/EP3589646A4/en active Pending
- 2018-03-02 CN CN201880025103.XA patent/CN110831961B/zh active Active
- 2018-03-02 KR KR1020197029002A patent/KR102746901B1/ko active Active
- 2018-03-02 SG SG11201907922PA patent/SG11201907922PA/en unknown
- 2018-03-02 CA CA3055202A patent/CA3055202A1/en active Pending
- 2018-03-02 AU AU2018227583A patent/AU2018227583B2/en active Active
- 2018-03-02 JP JP2019568594A patent/JP7341900B2/ja active Active
- 2018-03-02 SG SG10202001869VA patent/SG10202001869VA/en unknown
- 2018-03-02 WO PCT/US2018/020741 patent/WO2018161017A1/en unknown
-
2023
- 2023-08-11 AU AU2023214349A patent/AU2023214349A1/en active Pending
- 2023-08-30 JP JP2023139792A patent/JP2023164900A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2020511529A5 (enrdf_load_stackoverflow) | ||
CN112639102B (zh) | 抗间皮素嵌合抗原受体(car)构建体及其用途 | |
US12060394B2 (en) | Nucleic acid constructs for co-expression of chimeric antigen receptor and transcription factor, cells containing and therapeutic use thereof | |
JP2020525536A5 (enrdf_load_stackoverflow) | ||
JP2022130485A (ja) | 哺乳動物細胞における薬物リガンドの誘導による導入遺伝子の発現に対する感受性が増強されたキメラ転写因子バリアント | |
US11220535B2 (en) | Anti-BCMA chimeric antigen receptors | |
KR20230129983A (ko) | 조작된 세포 요법을 위한 표적화된 사이토카인 구축물 | |
TW202023580A (zh) | 使用靶特異性融合蛋白進行tcr再程式化之組合物及方法 | |
US20200399393A1 (en) | Dimeric Antigen Receptors | |
CA3177394A1 (en) | Method and compositions for cellular immunotherapy | |
US20220251168A1 (en) | Dimeric Antigen Receptors (DAR) that Bind BCMA | |
JP2025511872A (ja) | 多部位受容体及びシグナル伝達複合体 | |
US20220133792A1 (en) | Signaling platforms for chimeric antigen receptor t cells | |
US20200347148A1 (en) | Methods for enhancing and maintaining car-t cell efficacy | |
US20250109182A1 (en) | TGF-beta Receptors and Methods of Use | |
US20240226154A9 (en) | Car-t constructs comprising a novel cd19 binder combined with il18 and methods of using the same | |
EP4196231A1 (en) | Chimeric antigen receptor t cells for treating autoimmunity | |
CN113646433B (zh) | 靶向抗TNF-α抗体的组合物和方法 | |
US20250121007A1 (en) | Compositions for the treatment of cancer | |
WO2023133424A2 (en) | Compositions and methods for tcr reprogramming using fusion proteins and anti-pd-1 fusion peptides | |
JPWO2021046432A5 (enrdf_load_stackoverflow) |